Transplantation of FcγRIIb−/− BM cells into recipient mice impaired the CML phenotype, including a reduction of leukemic LSK cells using a retroviral and transgenic CML mouse model. Here, FCGR2B is linked to chronic myelogenous leukemia, BCR-ABL1 positive.